11-(4-(DIMETHYLAMINO)PHENYL)-5,17-DIHYDROXY-19-NORPREGN-9-ENE-3,20-DIONE CYCLIC BIS(1,2-ETHANEDIYL ACETAL), (5.ALPHA.,11.BETA.)-
UNII D3MFZ8ECV9

Substance Identification & Data

This profile provides standardized clinical and technical data for 11-(4-(dimethylamino)phenyl)-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione Cyclic Bis(1,2-ethanediyl Acetal), (5.alpha.,11.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D3MFZ8ECV9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 126690-41-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D3MFZ8ECV9
CAS Registry Number
126690-41-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
11-(4-(DIMETHYLAMINO)PHENYL)-5,17-DIHYDROXY-19-NORPREGN-9-ENE-3,20-DIONE CYCLIC BIS(1,2-ETHANEDIYL ACETAL), (5.ALPHA.,11.BETA.)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C32H45NO6
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
FBRARNYJAASEAN-UFXAQBIISA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
15085870
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O[C@]1([C@]2(C)[C@@](CC1)([C@]3(C([C@H](C2)c4ccc(N(C)C)cc4)=C5[C@@](O)(CC3)CC6(CC5)OCCO6)[H])[H])C7(C)OCCO7

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 11-(4-(dimethylamino)phenyl)-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione Cyclic Bis(1,2-ethanediyl Acetal), (5.alpha.,11.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(5R,8S,11R,13S,14S,17R)-11-(4-(DIMETHYLAMINO)PHENYL)-13-METHYL-17-(2-METHYL-1,3-DIOXOLAN-2-YL)-1,2,6,7,8,11,12,13,14,15,16,17-DODECAHYDROSPIRO(CYCLOPENTA(A)PHENANTHRENE-3,2'-(1,3)DIOXOLANE)-5,17(4H)-DIOL
11-(4-(DIMETHYLAMINO)PHENYL)-5,17-DIHYDROXY-19-NORPREGN-9-ENE-3,20-DIONE CYCLIC BIS(1,2-ETHANEDIYL ACETAL), (5.ALPHA.,11.BETA.)-
19-NORPREGN-9-ENE-3,20-DIONE, 11-(4-(DIMETHYLAMINO)PHENYL)-5,17-DIHYDROXY-, CYCLIC 3,20-BIS(1,2-ETHANEDIYL ACETAL), (5.ALPHA.,11.BETA.)-
19-NORPREGN-9-ENE-3,20-DIONE, 11-(4-(DIMETHYLAMINO)PHENYL)-5,17-DIHYDROXY-, CYCLIC BIS(1,2-ETHANEDIYL ACETAL), (5.ALPHA.,11.BETA.)-
3,3,3,20,20-BIS(ETHYLENE-DIOXY)-5.ALPHA., 17.ALPHA.-DIHYDROXY-11.BETA.-(4-(N,N-DIMETHYLAMINO)-PHENYL)-19-NORPREGNA-9(11)-ENE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound